347 related articles for article (PubMed ID: 25986251)
1. Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice.
Panje CM; Dal Pra A; Zilli T; R Zwahlen D; Papachristofilou A; Herrera FG; Matzinger O; Plasswilm L; Putora PM
Strahlenther Onkol; 2015 Oct; 191(10):778-86. PubMed ID: 25986251
[TBL] [Abstract][Full Text] [Related]
2. Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy : A national survey on patterns of practice.
Dal Pra A; Panje C; Zilli T; Arnold W; Brouwer K; Garcia H; Glatzer M; Gomez S; Herrera F; Kaouthar K; Papachristofilou A; Pesce G; Reuter C; Vees H; Zwahlen DR; Engeler D; Putora PM
Strahlenther Onkol; 2018 Jan; 194(1):9-16. PubMed ID: 28656373
[TBL] [Abstract][Full Text] [Related]
3. ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancer.
Schmidt-Hegemann NS; Zamboglou C; Mason M; Mottet N; Hinnen K; De Meerleer G; Cozzarini C; Maingon P; Henry A; Spahn M; Cornford P; Belka C; Wiegel T
Radiother Oncol; 2023 Jun; 183():109544. PubMed ID: 36813168
[TBL] [Abstract][Full Text] [Related]
4. Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer.
Zelefsky MJ; Moughan J; Owen J; Zietman AL; Roach M; Hanks GE
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1053-61. PubMed ID: 15234039
[TBL] [Abstract][Full Text] [Related]
5. The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer.
Shilkrut M; Merrick GS; McLaughlin PW; Stenmark MH; Abu-Isa E; Vance SM; Sandler HM; Feng FY; Hamstra DA
Cancer; 2013 Feb; 119(3):681-90. PubMed ID: 22893254
[TBL] [Abstract][Full Text] [Related]
6. Redefining high-risk prostate cancer based on distant metastases and mortality after high-dose radiotherapy with androgen deprivation therapy.
Tendulkar RD; Reddy CA; Stephans KL; Ciezki JP; Klein EA; Mahadevan A; Kupelian PA
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1397-404. PubMed ID: 21665379
[TBL] [Abstract][Full Text] [Related]
7. Quality indicators for prostate radiotherapy: are patients disadvantaged by receiving treatment in a 'generalist' centre?
Freeman AR; Roos DE; Kim L
J Med Imaging Radiat Oncol; 2015 Apr; 59(2):255-64. PubMed ID: 25345594
[TBL] [Abstract][Full Text] [Related]
8. Practice patterns of primary EBRT with and without ADT in prostate cancer treatment.
Schmidt B; Eapen RS; Cowan JE; Broering JM; Greene KL; Carroll PR; Cooperberg MR
Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):117-124. PubMed ID: 30171230
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the Rate of Adherence to International Guidelines for Androgen Deprivation Therapy with External-beam Radiation Therapy: A Population-based Study.
Dell'Oglio P; Abou-Haidar H; Leyh-Bannurah SR; Tian Z; Larcher A; Gandaglia G; Fossati N; Shariat SF; Capitanio U; Briganti A; Montorsi F; Graefen M; Saad F; Karakiewicz PI
Eur Urol; 2016 Sep; 70(3):429-35. PubMed ID: 26951945
[TBL] [Abstract][Full Text] [Related]
10. Long-term androgen deprivation, with or without radiotherapy, in locally advanced prostate cancer: updated results from a phase III randomised trial.
Sargos P; Mottet N; Bellera C; Richaud P
BJU Int; 2020 Jun; 125(6):810-816. PubMed ID: 30946523
[TBL] [Abstract][Full Text] [Related]
11. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
Demanes DJ; Brandt D; Schour L; Hill DR
Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
[TBL] [Abstract][Full Text] [Related]
12. High-dose radiotherapy with or without androgen deprivation therapy for intermediate-risk prostate cancer: cancer control and toxicity outcomes.
Edelman S; Liauw SL; Rossi PJ; Cooper S; Jani AB
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1473-9. PubMed ID: 22245201
[TBL] [Abstract][Full Text] [Related]
13. Is androgen deprivation therapy necessary in all intermediate-risk prostate cancer patients treated in the dose escalation era?
Castle KO; Hoffman KE; Levy LB; Lee AK; Choi S; Nguyen QN; Frank SJ; Pugh TJ; McGuire SE; Kuban DA
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):693-9. PubMed ID: 22836052
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
Amit U; Lawrence YR; Weiss I; Symon Z
Radiat Oncol; 2019 Jun; 14(1):99. PubMed ID: 31182119
[TBL] [Abstract][Full Text] [Related]
15. Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk disease.
Stenmark MH; Blas K; Halverson S; Sandler HM; Feng FY; Hamstra DA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e335-44. PubMed ID: 21645976
[TBL] [Abstract][Full Text] [Related]
16. Interval to biochemical failure predicts clinical outcomes in patients with high-risk prostate cancer treated by combined-modality radiation therapy.
Shilkrut M; McLaughlin PW; Merrick GS; Vainshtein JM; Feng FY; Hamstra DA
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):721-8. PubMed ID: 23664325
[TBL] [Abstract][Full Text] [Related]
17. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
[TBL] [Abstract][Full Text] [Related]
18. [Radiation therapy of locally advanced prostate cancer].
Schmidt-Hegemann NS; Li M; Eze C; Belka C; Ganswindt U
Urologe A; 2017 Nov; 56(11):1402-1409. PubMed ID: 28983664
[TBL] [Abstract][Full Text] [Related]
19. External beam radiotherapy for prostate cancer.
Pinkawa M
Panminerva Med; 2010 Sep; 52(3):195-207. PubMed ID: 21045776
[TBL] [Abstract][Full Text] [Related]
20. Impact of concurrent androgen deprivation on fiducial marker migration in external-beam radiation therapy for prostate cancer.
Tiberi DA; Carrier JF; Beauchemin MC; Nguyen TV; Béliveau-Nadeau D; Taussky D
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):e7-e12. PubMed ID: 22541962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]